Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

A need for the EU to scrutinise self testing

This article was originally published in SRA

Executive Summary

As the European Union adopts a more patient-centric approach to healthcare and emphasises the need for patient choice, the diagnostics industry is exploiting this opportunity to introduce an increasing variety of self-test kits. This development is also being spurred on by member states’ growing requirements for patients to take more responsibility for their own health, both on a financial and practical level. But has it gone too far?

Latest Headlines
See All
UsernamePublicRestriction

Register

MT038882

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel